Zinc Acetate (Lozenges).
Dissolved slowly in the mouth, it releases ionic zinc right at the throat surface, where zinc supports normal immune defence at the mucosal barrier.
Reviewed March 2026
- Category
- Mineral
- Also filed under
- Cold TreatmentThroatIonic Zinc
What Zinc Acetate (Lozenges) is, and what it does.
- Does it work
- Suits people who want zinc acting locally in the throat during the colder months. If you already take daily zinc, count the lozenges into your total.
- How much to take
- Start with 30mg to 75mg of zinc a day spread across lozenges sucked slowly, run over a short stretch of days rather than continuously.
- Time to feel it
- The zinc reaches the throat surface within the few minutes it takes to dissolve one. Anything past that local effect is measured across days.
- The first dose
- A metallic taste and a coated throat are the usual day one. The taste is strong, and having something in your stomach first helps.
- With regular use
- It is built for short runs, not months. Sustained zinc at these amounts lowers copper absorption, so courses with breaks fit the format better.
- How well tolerated
- Well tolerated across a short course. Metallic taste, dry mouth and nausea are the usual complaints. Long high-zinc intake lowers copper, so keep runs short.
- How it feels
- Strongly metallic, sometimes chalky, with a coated feeling in the throat afterwards. People put up with the taste for what it is doing locally.
- The overlooked benefit
- The sweetener decides the dose. Citrate, tartrate, sorbitol and mannitol all bind zinc and cut how much free ion the lozenge actually releases.
8 to 15mg a day is where Zinc Acetate (Lozenges) works.
Source: NIH ODS + Prasad 2008 zinc review
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Zinc Acetate (Lozenges) has emerging evidence. Based on 52+ studies.
- mucosal immune defence in the nose and throatMeta-analysis
- normal immune system functionMeta-analysis
- free ionic zinc release as a function of lozenge baseIn vitro study
- normal taste perceptionRandomised trial
Questions people ask about Zinc Acetate (Lozenges).
- Why acetate specifically?
- Acetate releases free ionic zinc better than other forms. Gluconate works too. Citrate doesn't.
- Why can't I just swallow zinc pills?
- For colds, zinc needs to be in your throat where the virus replicates. Swallowing bypasses this.
- How bad is the taste?
- Pretty bad. Metallic. But a shorter cold is worth it for most people.
- Can I use these daily for prevention?
- No. High-dose zinc long-term can cause copper deficiency and other issues. Cold use only.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
A lozenge works by releasing free zinc ions onto oropharyngeal tissue, and citrate is a strong enough chelator to hold those ions and reduce the free fraction. Formulators keep citrate and other strong ligands out of ionic zinc lozenges for this reason.
Ascorbic acid is a mild zinc chelator, so combining it into an ionic zinc lozenge lowers the free ion the format depends on, even though the two are routinely paired in swallowed formulas. The interaction is about the delivery format, not the nutrients themselves.
Zinc from a dissolved lozenge is also swallowed and absorbed, so repeated daily use induces metallothionein and lowers copper status. Short courses matter less than sustained ones.
Histidine coordinates zinc tightly, which raises absorption of a swallowed dose but lowers the free ionic zinc a lozenge needs at the mucosal surface. The same ligand chemistry helps one format and works against the other.
Whatever zinc is swallowed competes with non-heme iron for divalent transport in the small intestine. The competition applies to the systemic portion, not the local action.
Vitamin D supports normal immune cell regulation and raises expression of intestinal zinc transporters, which helps the swallowed fraction. It is a standard companion in seasonal formats.
Zinc-dependent superoxide dismutase and selenium-dependent glutathione peroxidase clear reactive species in sequence in activated cells. Both minerals are needed for the sequence to run.
Calcium competes with the swallowed zinc for divalent uptake, and dairy ligands also bind zinc in the mouth and lower the free ion. Lozenges are taken away from milk and calcium doses.
Zinc coordinates readily to the sulfhydryl group of cysteine, which is the same chemistry that holds zinc in zinc-finger proteins and in metallothionein. In a lozenge that matters twice over: a cysteine-containing base binds ionic zinc in the mouth and lowers the free ion fraction, while in the gut cysteine-rich ligands improve zinc solubility in the intestinal lumen. Which effect dominates depends on where the binding happens.
Zinc binds glutathione through its cysteine thiol, and the glutathione pool is one of the buffers that keeps free intracellular zinc in the picomolar range. Zinc in turn stabilises thiols against oxidation. The relationship is established cell biochemistry rather than a tested supplement combination.
Zinc and magnesium are both divalent cations absorbed in the small intestine, and a large bolus of one can lower fractional absorption of the other when they arrive together. For a lozenge the point is mostly moot, since the intended action is local release of ionic zinc in the mouth and throat rather than systemic delivery. Where a person also takes a high-dose magnesium product, spacing them apart removes the question.
Both minerals use overlapping divalent cation transport at the enterocyte, so sustained high zinc intake can lower manganese uptake. This is a dose-dependent competition rather than an all-or-nothing block. It is worth flagging in a multi-mineral product, less so for an occasional lozenge.
Inositol hexaphosphate binds zinc tightly in the gut lumen and forms an unabsorbable complex, which is why zinc absorption is lower from high-phytate plant meals. Phytase cleaves phosphate groups from the inositol ring and releases the bound zinc. The relationship is settled nutrition chemistry and is the basis for phytase use in feed and in food processing.
Retinol leaves the liver bound to retinol-binding protein, and hepatic synthesis of that carrier protein is zinc dependent. Zinc is also required by the dehydrogenase that converts retinol to retinal. Low zinc status therefore limits how much vitamin A the body can mobilise regardless of vitamin A intake, a textbook interdependence.
Dietary folates arrive as polyglutamates and must be hydrolysed to the monoglutamate before absorption, a step catalysed by a zinc-requiring brush border enzyme. Adequate zinc is therefore part of how folate from food becomes absorbable. Reports of high folic acid intake reducing zinc absorption exist and are less consistent, so that direction is weaker.
Amino acids coordinate zinc through their amine and carboxyl groups, and glycine is a common lozenge excipient chosen partly because it dissolves pleasantly in the mouth. That same binding lowers the concentration of free ionic zinc released during sucking, which is the property the lozenge format is built around. Formulators pick base ingredients with this in mind rather than by taste alone.
Protein digestion products bind zinc loosely and hold it in solution at intestinal pH, where it would otherwise precipitate as a hydroxide or bind to phytate. This is why zinc absorption from a mixed protein meal tends to exceed absorption from a high-phytate plant meal at the same intake. It is a solubility effect described in absorption studies, not a claim about a supplement pair.
Phosphoserine clusters in casein bind calcium and other divalent cations, and the same clusters can sequester zinc. Reports differ on whether the net effect on zinc uptake is positive or negative, since binding both keeps zinc soluble and holds it away from the transporter. The direction is unsettled and the pairing is flagged rather than recommended.
Dihydrolipoic acid carries two thiols and is described as a metal-binding agent in redox chemistry work. Zinc is among the ions it can coordinate. The interaction is characterised in vitro and its practical significance at supplement intakes has not been measured.
Carnosine coordinates zinc through its imidazole nitrogen and peptide backbone to form a polymeric chelate that is stable at gastric pH and dissociates slowly. That slow release is the whole reason the complexed form exists as a separate ingredient. It sits at the opposite end of the release spectrum from an acetate lozenge, which is designed to give up its zinc quickly in the mouth.
Methionine coordinates zinc through its amine and carboxyl groups, and the resulting complex is marketed as its own ingredient. Free methionine present alongside a zinc salt will form some of that complex in solution. The consequence is a change in the free ion fraction, which matters most for a format that depends on releasing ionic zinc locally.
Nothing specific on file for Zinc Acetate (Lozenges). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Zinc Acetate (Lozenges) actually does.
Zinc acetate is the zinc salt of acetic acid and dissociates in aqueous solution to Zn2+ and acetate; acetate is a weakly coordinating counterion, so the salt releases ionic zinc readily.
The lozenge format is designed to release zinc slowly in the mouth and throat over several minutes of sucking rather than to deliver it to the small intestine as a bolus.
How much free ionic zinc a lozenge releases depends on the rest of the formulation: citrate, tartrate, sorbitol, mannitol and amino acid bases all coordinate zinc and lower the free ion fraction, while the pH of the dissolved lozenge shifts the equilibrium further.
Acetate itself is a normal metabolic intermediate, activated to acetyl-CoA by acetyl-CoA synthetase and entering the citric acid cycle, so the counterion carries no separate mineral load.
Where Zinc Acetate (Lozenges) comes from.
Refined zinc is dissolved in vinegar acid, the resulting salt is crystallised out and tested, then pressed into a lozenge with sweeteners and flavour. Which sweeteners get used matters, because some of them hold onto the zinc.
Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.
Starting material is zinc metal or zinc oxide produced from refined zinc ore concentrate, at a purity grade that meets pharmaceutical or food specifications for lead, cadmium and arsenic.
Zinc oxide or zinc metal is reacted with food or pharmaceutical grade acetic acid in water, giving zinc acetate in solution; the reaction with the metal also evolves hydrogen.
The solution is filtered to remove unreacted solids and insolubles, then concentrated and cooled so zinc acetate dihydrate crystallises; crystals are washed and centrifuged.
Batches are assayed for zinc content and water of hydration and tested against heavy metal and microbial limits, then released against a monograph specification.
The salt is blended with a lozenge base, sweeteners, flavour and lubricant and compressed into a slow-dissolving tablet; base and pH choices determine how much free ionic zinc the lozenge gives up in the mouth.
Getting Zinc Acetate (Lozenges) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
Zinc Acetate (Lozenges) is a form of Zinc.
Zinc Acetate (Lozenges) is the acetate form of Zinc. Same mineral, bound to a different partner, so absorption and feel differ from form to form.
See the other 13 forms
The essence, in one line each.
- The review authors judged the evidence for zinc lozenges on the duration of acute upper respiratory symptoms in adults to be of low certainty, with results that varied across trials; failure to reach a confident conclusion is not evidence that no effect exists.Systematic review. Nault D et al., 2024 (Cochrane Database of Systematic Reviews). PMID 38719213 β
- The earlier version of this review pooled zinc lozenge and syrup trials and reported shorter symptom duration in the zinc arms, while noting variable trial quality, differing zinc salts and doses, and taste-related unblinding.Systematic review. Singh M et al., 2013 (Cochrane Database of Systematic Reviews). PMID 23775705 β
- A reference summary of zinc chemistry, physiological roles and intake considerations; it describes zinc as a catalytic and structural cofactor and notes that sustained high intakes reduce copper absorption.Narrative review. Reference monograph entry, 2006 (source record indexed as Zinc). PMID 35230756 β
These are the studies our verdict leans on, chosen from the 3 we read for Zinc Acetate (Lozenges). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.